Expected Impact:
The action under this topic is expected to achieve all the following impacts and contribute to the following EU policies/initiatives:
- decrease the CVD burden in European cities by the reduction of CV events, disability, and mortality;
- enable future clinical pathways leading to improved patient outcomes;
- reduce the pressure of patient flow in the healthcare system via innovative diagnostic/detection solutions;
- strengthen the definition, standardisation and selection of performance indicators on CVD mortality, patient outcomes and economic impact of interventions, and thus improve future clinical pathways and intervention implementation studies;
- optimise healthcare expenditure to tackle the financial strain of CVD, amounting to EUR282 billion annually in the EU [1]. The emphasis is on prioritising spending for maximum efficiency and value, balancing the costs of advanced interventions with their long-term benefits;
- strengthen public awareness initiatives and incorporate improved diagnostic methods to enhance early detection and treatment of CVD, to reduce premature CVD deaths and support preventive healthcare measures;
- strengthen patient and citizen input to treatment pathways, disease monitoring and scientific guideline enhancement;
- contribute to the European policy on Active and Healthy Aging , and to the implementation of the European Commission's proposal for the European Health Data Space (EHDS) by providing FAIR data that are aligned with the EHDS
